Patients at Henry Ford Hospital now have a new cancer treatment available that offers an alternative cancer surgery, without the incision or hospital stay, treating patients in 15 minutes or less and returning them to their everyday lives.
The Edge™ Radiosurgery Suite is designed to perform advanced, non-invasive cancer procedures anywhere in the body – including the brain, spine, head and neck, adrenal gland, lung, liver and pancreas – with extreme precision and low toxicity.
It is the first unit in North America and only available at the Josephine Ford Cancer Institute at Henry Ford Hospital.
The Edge, created by Varian Medical Systems, uses new real-time tumor tracking technology and motion management capabilities, improving both safety and comfort for patients by protecting healthy tissue with sub-millimeter-accuracy. And its “cutting edge” beam offers the agility to treat tumors that may be difficult to reach surgically.
Treatments are typically outpatient and completed within the same week – with only one to five sessions.
Patients will begin treatment using the Edge this week at Henry Ford Hospital.
A pioneer in the use stereotactic radiation therapy, Henry Ford’s Department of Radiation Oncology has treated more than 4,000 patients using this specialized type of stereotactic radiation therapy.
And now, the Edge offers patients:
• Faster treatment: With a dose rate of up to 2,400 monitor units per minute, it offers rapid stereotactic treatments in only 10-20 minutes compared to other systems that can take well over an hour per session.
• Increased comfort: The six degrees (6D) of freedom treatment couch provides the accuracy, precision and flexibility needed to optimally position and adjust patients, allowing them to be comfortable and breathe freely during treatment.
• Real-time imaging: An advanced motion management package makes it possible to better compensate for tumor motion during treatment. The 2.5mm multi-leaf collimator provides a distinct cutting “edge” for radiosurgery treatments.
• Cost-effective medicine: The Edge can accurately treat the vast majority of what a proton beam center can do at a fraction of the cost of a proton unit.
“Henry Ford’s Department of Radiation Oncology has a long tradition of expertise with the most advanced radiation technologies, a heritage that will now continue with the addition the Edge,” says Benjamin Movsas, M.D., Chair of the Department of Radiation Oncology at Henry Ford.
“The Edge truly represents a novel platform in radiosurgery, offering a system that provides a fully-integrated solution for planning and administering radiosurgery treatments.”
“In radiosurgery, millimeters matter,” says neurosurgeon Steven N. Kalkanis, M.D., director of the Center for Cancer Surgery at Henry Ford. “The Edge radiosurgery suite is calibrated for sub-millimeter accuracy. That will help us rest assured that we are doing everything possible to protect normal tissues.”
Henry Ford Hospital was selected by Varian as the first site for the Edge in North American because it “represents and embodies clinical excellence and we are thrilled that we get to launch this exciting new platform into clinical use with them,” according to Chris Toth, vice president of marketing for Varian’s Oncology Systems business.
Henry Ford joins Champalimaud Foundation in Lisbon, Portugal, as the first two sites in the world with the Edge.
What is Stereotactic Radiation?
Stereotactic radiation is a procedure that precisely delivers intense radiation doses to tumor targets in one to five treatments. The goal of this non-invasive procedure is to destroy, or make inactive, the tumor while minimizing dose exposure to the surrounding healthy tissue.
The Latest on: Stereotactic Radiation
via Google News
The Latest on: Stereotactic Radiation
- Dr. Shinohara on the Future of Radiation and Surgery in Prostate Canceron January 24, 2020 at 2:31 pm
Eric Shinohara, MD, MSCI, associate professor and interim chair, Vanderbilt University Medical Center, discusses the future of stereotactic body radiation (SBRT) and surgery in prostate cancer. For ...
- Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.on January 24, 2020 at 5:53 am
Prostate SABR delivers large doses using a fast dose rate. This amplifies the effect geometric uncertainties have on normal tissue dose. The aim of this study was to determine whether the treatment ...
- Great debate: surgery versus stereotactic radiotherapy for early-stage non-small cell lung canceron January 22, 2020 at 4:35 am
Stereotactic ablative radiotherapy (SABR) for primary early-stage non-small cell lung cancer (NSCLC) is a precision therapy given over three to eight fractions, delivering a high dose to the tumour ...
- Radiotherapy Market: Technological Advancements Driving the Global Market Growthon January 16, 2020 at 4:26 pm
Based on type, the external beam radiotherapy market is classified into IGRT, IMRT, stereotactic therapy, particle beam therapy, and 3D-CRT. The IMRT segment is further classified into VMAT and ...
- Global Radiation Oncology Market Report 2025: Market Segments, Size,Trend and Market Projections for Upcoming Yearson January 14, 2020 at 8:53 am
modulated radiation therapy, stereotactic radiation, and 3D conformal radiation therapy, and other therapies. Based on the application, the market is bifurcated into blood Cancer, prostate cancer, ...
- Dr. Pranshu Mohindraon January 13, 2020 at 11:07 am
intensity modulated radiation therapy, stereotactic body radiation therapy, stereotactic radiotherapy and image-guided brachytherapy. He played a leading role in the initiation of his department’s MRI ...
- Radiosurgery Market| 2020 Global Growth Analysis, Size, Share, Future Plans and Forecast till 2026on January 13, 2020 at 2:58 am
Radiosurgery refers to an unconventional surgery method which is performed using radiation. It has two types – stereotactic and staged. In stereotactic radiosurgery, targeted radiation is delivered in ...
- Efficacy of a hydrogel spacer in three-dimensional conformal radiation therapy for prostate cancer.on January 13, 2020 at 12:07 am
We aimed to compare the dose constraints fulfillment rate of the three-dimensional conformal radiotherapy treatment plan before and after a hydrogel spacer insertion. The planning computed tomography ...
- The GammaPod: More Precise And Shorter Treatments For Breast Canceron January 12, 2020 at 7:36 pm
Listen Listening... 7:39 The KERA Interview with Dr. Asal Rahimi UTSW has been using a newer form of radiation therapy called stereotactic body radiation therapy. It is more precise, takes less time ...
- ‘I want to thank the Good Lord for His abundant grace in my healing’: Governor Ivey updates her recovery from lung canceron January 8, 2020 at 11:11 am
Following the exam, the governor’s physician, Dr. Alex Whitley, of Central Alabama Radiation Oncology, released this statement: “Governor Ivey is now three months removed from Stereotactic Body ...
via Bing News